P1474: HEMOLYTIC MARKERS, MORTALITY, AND THROMBOEMBOLIC EVENTS IN CAD: RISK ASSESSMENT BY TIME PERIOD SINCE DIAGNOSIS
Main Authors: | Quentin A Hill, Wilma Barcellini, Alexander Röth, Alia Karaouni, Marion Afonso, Yoo Ronnie, Julien Tanniou, Julien Rubio, Catherine M Broome |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000972780.33877.d7 |
Similar Items
-
Diagnosis and Management of Autoimmune Hemolytic Anemias
by: Wilma Barcellini, et al.
Published: (2022-10-01) -
The Changing Landscape of Autoimmune Hemolytic Anemia
by: Wilma Barcellini, et al.
Published: (2020-06-01) -
P1486: SERUM BIOMARKERS AS PREDICTORS OF RESPONSE TO SUTIMLIMAB IN COLD AGGLUTININ DISEASE (CAD): A POST-HOC ANALYSIS OF PHASE 3 CARDINAL AND CADENZA STUDY DATA
by: Wilma Barcellini, et al.
Published: (2023-08-01) -
Infectious Complications in Autoimmune Hemolytic Anemia
by: Juri Alessandro Giannotta, et al.
Published: (2021-01-01) -
Bortezomib in autoimmune hemolytic anemia and beyond
by: Raffaella Pasquale, et al.
Published: (2021-11-01)